First Oral Once-Daily Mesalamine For Ulcerative Colitis: LIALDA Available Now

http://www.medicalnewstoday.com/medicalnews.php?newsid=65634&nfid=rssfeeds
LIALDA is available to patients by prescription for oral administration in dosages of 2.4 g/day and 4.8 g/day, allowing patients to take as few as two tablets once daily. Other currently available mesalamines require three to four times daily dosing and six to 16 pills a day. A study found that patients who are not compliant with their mesalamine medications have a five-fold greater risk of disease flares, a serious worsening of symptoms, than compliant patients.